Remember the drug used by cancer and AIDS patients that skyrocketed from $13.50 to $750 a pill? Well, the price has yet to come back to earth. The company still has not cut the price below $750 even though it vowed that it would on national TV and in a public statement over two weeks ago.
Are you up for a challenge?
